Interestingly many bone turnover markers, including bone sialoprotein (BSP), collagen type I, and osteopontin (OPN) can be used as biomarkers for the diagnosis, prognosis, and evaluation of lung cancer bone metastases including that of NSCLC and SCLC [82,185,186,187]. This evidence concerns the gene IBSP and lung carcinoma.